Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8699056
Reference Type
Journal Article
Title
Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations
Author(s)
Verbalis, JG; Goldsmith, SR; Greenberg, A; Schrier, RW; Sterns, RH
Year
2007
Is Peer Reviewed?
1
Journal
American Journal of Medicine
ISSN:
0002-9343
EISSN:
1555-7162
Volume
120
Issue
11 SUPPL. 1
Page Numbers
S1-S21
Language
English
DOI
10.1016/j.amjmed.2007.09.001
Abstract
Although hyponatremia is a common, usually mild, and relatively asymptomatic disorder of electrolytes, acute severe hyponatremia can cause substantial morbidity and mortality, particularly in patients with concomitant disease. In addition, overly rapid correction of chronic hyponatremia can cause severe neurologic deficits and death, and optimal treatment strategies for such cases are not established. An expert panel assessed the potential contributions of aquaretic nonpeptide small-molecule arginine vasopressin receptor (AVPR) antagonists to hyponatremia therapies. This review presents their conclusions, including identification of appropriate treatment populations and possible future indications for aquaretic AVPR antagonists. 2007 Elsevier Inc. All rights reserved.
Keywords
Antidiuretic hormone; Aquaretics; Hypo-osmolality; Natriuresis; Syndrome of inappropriate antidiuretic hormone secretion; Vasopressin
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity